We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
MarineMax
HZO
$800M
| $604K | ﹤0.01% |
27,000
-7,600
| -22% | -$125K |
|
|
TPC
1177
Tutor Perini Cor
TPC
$4.57B
| $601K | ﹤0.01% |
+49,400
| New | +$442K |
|
1178
Enerpac Tool Group
EPAC
$1.77B
| $600K | ﹤0.01% |
+34,100
| New | +$576K |
|
1179
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $598K | ﹤0.01% |
23,500
-3,500
| -13% | -$73.1K |
|
1180
RH
RH
$3.3B
| $597K | ﹤0.01% |
2,400
+2,000
| +500% | +$362K |
|
1181
Kforce
KFRC
$983M
| $596K | ﹤0.01% |
20,400
+1,700
| +9% | +$49.5K |
|
1182
Vanda Pharmaceuticals
VNDA
$312M
| $596K | ﹤0.01% |
52,100
-6,000
| -10% | -$67.9K |
|
1183
Collegium Pharmaceutical
COLL
$1.14B
| $595K | ﹤0.01% |
34,000
+3,500
| +11% | +$68.5K |
|
|
ACH
1184
Accendra Health
ACH
$240M
| $595K | ﹤0.01% |
78,200
| – | – |
|
1185
V2X
VVX
$2.62B
| $594K | ﹤0.01% |
12,100
-1,500
| -11% | -$72.6K |
|
1186
York Water
YORW
$505M
| $594K | ﹤0.01% |
12,400
+1,000
| +9% | +$43.4K |
|
1187
Southwest Gas
SWX
$6.74B
| $593K | ﹤0.01% |
8,600
+700
| +9% | +$50.9K |
|
1188
Citi Trends
CTRN
$524M
| $592K | ﹤0.01% |
29,300
+1,400
| +5% | +$18.3K |
|
1189
Johnson Outdoors
JOUT
$482M
| $591K | ﹤0.01% |
6,500
-1,100
| -14% | -$78.6K |
|
|
NTUS
1190
DELISTED
Natus Medical Inc
NTUS
| $591K | ﹤0.01% |
27,100
-108,000
| -80% | -$2.47M |
|
1191
Adtran
ADTN
$798M
| $590K | ﹤0.01% |
54,000
+7,600
| +16% | +$78.5K |
|
|
HA
1192
DELISTED
Hawaiian Holdings, Inc.
HA
| $589K | ﹤0.01% |
42,000
+3,500
| +9% | +$47.7K |
|
|
NXGN
1193
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $586K | ﹤0.01% |
53,400
+5,500
| +11% | +$57K |
|
|
BBT
1194
Beacon Financial Corp
BBT
$2.53B
| $585K | ﹤0.01% |
53,100
+21,000
| +65% | +$270K |
|
|
EGRX
1195
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $585K | ﹤0.01% |
12,200
+400
| +3% | +$20K |
|
1196
PC Connection
CNXN
$2.05B
| $584K | ﹤0.01% |
12,600
-1,000
| -7% | -$42.1K |
|
1197
Carvana
CVNA
$43.3B
| $581K | ﹤0.01% |
+24,175
| New | +$453K |
|
1198
Herc Holdings
HRI
$5.43B
| $580K | ﹤0.01% |
18,900
+1,700
| +10% | +$43.6K |
|
|
DCPH
1199
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $579K | ﹤0.01% |
9,700
-3,100
| -24% | -$166K |
|
1200
Spire
SR
$4.92B
| $578K | ﹤0.01% |
8,800
+700
| +9% | +$49.9K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.